A Research Program Targeting Pre- and Peri-transplant Optimization Program (R-PPOP)

Duke University1 site in 1 country29 target enrollmentJune 27, 2019

ConditionsHematologic Malignancy

Overview

Phase: N/A
Intervention: Not specified
Conditions: Hematologic Malignancy
Sponsor: Duke University
Enrollment: 29
Locations: 1
Primary Endpoint: Number of Participants Who Completed at Least Half of Their High Intensity Interval Training Sessions
Status: Active, Not Recruiting
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to evaluate the feasibility and outcomes of a research pre- and peri-transplant optimization program (R-PPOP) to improve multiple domains of health including physical function, cognitive function, mental health, and diet and nutrition for patients planning to undergo or undergoing hematopoietic stem cell transplantation (HCT).

Registry

clinicaltrials.gov

Start Date

June 27, 2019

End Date

May 1, 2024

Last Updated

3 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Duke University

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Plan to undergo an allogeneic hematopoietic stem cell transplant for any cancer or non-cancer illness within the next 6 months
•Age 18-80 years

Exclusion Criteria

•Both patient and caregiver are unable to read and follow directions in English (ok if only patient cannot read and follow directions in English as caregiver will be able to help).
•Any absolute contraindications to exercise:
•recent (\< 6 months) acute cardiac event;
•unstable angina;
•uncontrolled dysrhythmias causing symptoms or hemodynamic compromise;
•symptomatic aortic stenosis;
•uncontrolled symptomatic heart failure;
•acute pulmonary embolus;
•acute myocarditis or pericarditis;
•suspected or known dissecting aneurism; or